New pesticides are required to maintain effective resistance management strategies for control of western flower thrips, Frankliniella occidentalis (Pergande) (Thysanoptera: Thripidae). We tested the efficacy of acetamiprid, and thiamethoxam, two neonicotinoids that represent a newer class of insecticides for the control of thrips. We also tested chlorfenapyr, a pyrrol compound, and a lower than registered rate of the biopesticide spinosad. Laboratory bioassays were used to predict the relative efficacy of insecticides against F. occidentalis and to forecast likely field rates. Two doses within the calculated LC99.99 range were used to predict field rates and trial rates of 0.5 g and 1.0 active ingredient (AI)/liter acetamiprid, 0.025 and 0.05g (AI)/liter chlorfenapyr, 0.3 and 0.6g (AI)/literthiamethoxam, and 0.01 g (AI)/liter spinosad were tested in the greenhouse against pepper, lettuce, and tomato. With the exception of acetamiprid, field trial doses predicted from laboratory bioassay translated to effective field efficacy. All products controlled F. occidentalis at the rates trialed and so have potential to augment current chemical controls. Increasing mortality correlated with increasing acetamiprid concentration in a greenhouse lettuce trial, suggesting that the higher trial rate (1.0 g [AI]/liter) may be required in some lettuce crops. The lower than registered (0.01 g [AI]/liter) rate of spinosad also significantly reduced F. occidentalis numbers and is a viable control option that may be useful in specific integrated pest management programs. The implications of introducing neonicotinoids into existing insecticide resistance management strategies for F. occidentalis are discussed.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 102 • No. 2